Peggy Sotiropoulou

Company: T-knife Therapeutics
Job title: Chief Scientific Officer
Seminars:
Combining Best-in-Class TCRs, Next Generation Technologies & Optimal Manufacturing to Mediate Optimal Anti-Tumor Response 3:00 pm
MyT platformTM, a unique T-cell receptor and unbiased epitope discovery engine Next-generation approaches to engage the broader immune system and promote resistance to the tumor microenvironment Process development that selects for memory phenotypeRead more
day: Conference Day Two
Industry Leaders’ Fireside Chat: What’s Next for T-Cell Receptor Therapies? 8:15 am
Appreciating the wealth of TCR therapy advances and exploring the data to secure clinical validation Examining the range of TCR modalities and their respective targeting benefits Discussing the advances in allogeneic TCR approaches to determine the future directions for TCR therapiesRead more
day: Conference Day One